𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia

✍ Scribed by Nicoletta M.J. van Veelen; Koen. P. Grootens; J. Peuskens; B.G.C. Sabbe; Miriam E. Salden; R.J. Verkes; René S. Kahn; Margriet M. Sitskoorn

Book ID
119365532
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
214 KB
Volume
120
Category
Article
ISSN
0920-9964

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neurocognition and its influencing facto
Neurocognition and its influencing factors in the treatment of schizophrenia—effects of aripiprazole, olanzapine, quetiapine and risperidone
✍ M. Riedel; R. Schennach-Wolff; R. Musil; S. Dehning; A. Cerovecki; M. Opgen-Rhei 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 2 views

## Abstract ## Background To examine influencing variables of neurocognition in patients with schizophrenia and to predict cognition during antipsychotic treatment. ## Methods Data were obtained from patients with an acute episode of schizophrenia participating in two double‐blind and one open l

A pilot study of intramuscular ziprasido
A pilot study of intramuscular ziprasidone in the short-term treatment of patients with acute exacerbation of schizophrenia
✍ Shlomo Brook 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

Ziprasidone is a novel antipsychotic which, in oral formulation, has been shown to be effective and well tolerated in the treatment of acute psychosis. This pilot study examined the efficacy and tolerability of the intramuscular (IM) formulation and the transition from IM to oral ziprasidone in pati